{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:02Z","timestamp":1788873182343,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI181219"],"award-info":[{"award-number":["R01AI181219"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cerebral malaria is a complication of\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      infections where the integrity of the blood\u2013brain barrier (BBB) is compromised, frequently leading to persistent neurological sequelae or death. The current treatment for cerebral malaria is based on rapid elimination of the parasite with intravenous anti-malarial drugs, but there is no adjunctive treatment that could address the loss of BBB integrity, potentially decreasing sequelae and improving the survival rate. Prenylation, a cellular process that incorporates isoprenoid lipids to specific protein sites, is known to regulate endothelial barrier integrity. Here we have studied the role of the isoprenoid farnesyl pyrophosphate (farnesyl-PP) and of different inhibitors of the enzymes that perform prenylation in endothelial cells to determine their effect on the endothelial barrier disruption induced by\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An in vitro model using human brain microvascular endothelial cells (HBMECs) incubated with lysates of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      -infected red blood cells (iRBCs) and a mouse model of cerebral malaria were used to study the role of the two main prenylation enzymes, farnesyltransferase and geranylgeranyltransferase, in the regulation of endothelial barrier integrity in relation to cerebral malaria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Addition of exogenous farnesyl-PP to HBMECs incubated with\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      -iRBCs resulted in increased endothelial barrier disruption. Conversely, treatment with inhibitors of farnesyltransferase, but not of geranylgeranyltransferase, resulted in protection of barrier integrity against disruption induced by\n                      <jats:italic>P. falciparum-<\/jats:italic>\n                      iRBCs. Mice infected with\n                      <jats:italic>Plasmodium berghei<\/jats:italic>\n                      that were treated with the farnesyltransferase inhibitor tipifarnib presented delayed onset of cerebral malaria and higher survival rates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Inhibitors of farnesyltransferase protect human endothelial cell barrier integrity from disruption induced by\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      in vitro and decrease mortality in mice with experimental cerebral malaria, indicating a role for farnesylation in the regulation of barrier integrity during cerebral malaria and identifying a potential drug target for the protection of the endothelium during severe malaria.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-026-05981-2","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:27:02Z","timestamp":1782192422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasmodium-induced disruption of brain endothelial barrier integrity in vitro and in mice is prevented by inhibitors of farnesyltransferase"],"prefix":"10.1186","volume":"25","author":[{"given":"Cl\u00e1udia","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Borges Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizeth","family":"Chicas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Salzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"5981_CR1","unstructured":"WHO: World Malaria Report. 2024."},{"key":"5981_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pt.2023.11.005","volume":"40","author":"SC Wassmer","year":"2024","unstructured":"Wassmer SC, de Koning-Ward TF, Grau GER, Pai. Unravelling mysteries at the perivascular space: a new rationale for cerebral malaria pathogenesis. Trends Parasitol. 2024;40:28\u201344.","journal-title":"Trends Parasitol"},{"key":"5981_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1203\/PDR.0b013e3181eee738","volume":"68","author":"R Idro","year":"2010","unstructured":"Idro R, Marsh K, John CC, Newton. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res. 2010;68:267\u201374.","journal-title":"Pediatr Res"},{"key":"5981_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-7258(98)00008-4","volume":"79","author":"CR Newton","year":"1998","unstructured":"Newton CR. Severe falciparum malaria in children current understanding of pathophysiology and supportive treatment. Pharmacol Ther. 1998;79:1\u201353.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"5981_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12936-018-2195-7","volume":"17","author":"R Varo","year":"2018","unstructured":"Varo R, Crowley VM, Sitoe A, Madrid L, Serghides L, Kain KC, et al. Adjunctive therapy for severe malaria: a review and critical appraisal. Malar J. 2018;17(1):47.","journal-title":"Malar J"},{"key":"5981_CR6","first-page":"385","volume":"119","author":"GG MacPherson","year":"1985","unstructured":"MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol. 1985;119:385\u2013401.","journal-title":"Am J Pathol"},{"key":"5981_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4269\/ajtmh.2003.69.345","volume":"69","author":"E Pongponratn","year":"2003","unstructured":"Pongponratn E, Turner GD, Day NP, Phu NH, Simpson JA, Stepniewska K, et al. An ultrastructural study of the brain in fatal plasmodium falciparum malaria. Am J Trop Med Hyg. 2003;69:345\u201359.","journal-title":"Am J Trop Med Hyg"},{"key":"5981_CR8","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1172\/JCI87306","volume":"126","author":"J Gallego-Delgado","year":"2016","unstructured":"Gallego-Delgado J, Basu-Roy U, Ty M, Alique M, Fernandez-Arias C, Movila A, et al. Angiotensin receptors and \u03b2-catenin regulate brain endothelial integrity in malaria. J Clin Invest. 2016;126:4016\u201329.","journal-title":"J Clin Invest"},{"key":"5981_CR9","volume":"13","author":"M Zuniga","year":"2022","unstructured":"Zuniga M, Gomes C, Chen Z, Martinez C, Devlin JC, Loke P, et al. Plasmodium falciparum and TNF-alpha differentially regulate inflammatory and barrier integrity pathways in human brain endothelial cells. Bio. 2022;13:e0174622.","journal-title":"Bio"},{"key":"5981_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.molmed.2020.11.006","volume":"27","author":"L Claesson-Welsh","year":"2021","unstructured":"Claesson-Welsh L, Dejana E, McDonald. Permeability of the endothelial barrier: identifying and reconciling controversies. Trends Mol Med. 2021;27:314\u201331.","journal-title":"Trends Mol Med"},{"key":"5981_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/ijms21010002","volume":"21","author":"M Aslam","year":"2019","unstructured":"Aslam M, Troidl C, Tanislav C, Rohrbach S, Gunduz D, Hamm CW. Inhibition of protein prenylation of GTPases alters endothelial barrier function. Int J Mol Sci. 2019;21:2.","journal-title":"Int J Mol Sci"},{"key":"5981_CR12","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1038\/labinvest.3780385","volume":"81","author":"V Krump-Konvalinkova","year":"2001","unstructured":"Krump-Konvalinkova V, Bittinger F, Unger RE, Peters K, Lehr HA, Kirkpatrick. Generation of human pulmonary microvascular endothelial cell lines. Lab Invest. 2001;81:1717\u201327.","journal-title":"Lab Invest"},{"issue":"1","key":"5981_CR13","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1038\/s41598-023-32035-3","volume":"13","author":"NO Abutaleb","year":"2023","unstructured":"Abutaleb NO, Atchison L, Choi L, Bedapudi A, Shores K, Gete Y, et al. Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome. Sci Rep. 2023;13(1):5032.","journal-title":"Sci Rep"},{"issue":"10","key":"5981_CR14","doi-asserted-by":"publisher","first-page":"114783","DOI":"10.1016\/j.celrep.2024.114783","volume":"43","author":"SA Bhat","year":"2024","unstructured":"Bhat SA, Vasi Z, Jiang L, Selvaraj S, Ferguson R, Salarvand S, et al. Geranylgeranylated SCFFBXO10 regulates selective outer mitochondrial membrane proteostasis and function. Cell Rep. 2024;43(10):114783.","journal-title":"Cell Rep"},{"key":"5981_CR15","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.1158\/1078-0432.CCR-18-3399","volume":"25","author":"A Kazi","year":"2019","unstructured":"Kazi A, Xiang S, Yang H, Chen L, Kennedy P, Ayaz M, et al. Dual farnesyl and geranylgeranyl transferase inhibitor thwarts mutant KRAS-driven patient-derived pancreatic tumors. Clin Cancer Res. 2019;25:5984\u201396.","journal-title":"Clin Cancer Res"},{"key":"5981_CR16","doi-asserted-by":"publisher","first-page":"101157","DOI":"10.1016\/j.neo.2025.101157","volume":"63","author":"DB Manikandan","year":"2025","unstructured":"Manikandan DB, Jagadeeshan S, Mathukkada S, Shareb RA, Prasad M, Belsamma LVS, et al. Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancers. Neoplasia. 2025;63:101157.","journal-title":"Neoplasia"},{"key":"5981_CR17","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.onc.1201656","volume":"16","author":"J Sun","year":"1998","unstructured":"Sun J, Qian Y, Hamilton AD, Sebti SM. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts. Oncogene. 1998;16:1467\u201373.","journal-title":"Oncogene"},{"key":"5981_CR18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1021\/jm9900873","volume":"42","author":"A Vasudevan","year":"1999","unstructured":"Vasudevan A, Qian Y, Vogt A, Blaskovich MA, Ohkanda J, Sebti SM, et al. Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I. J Med Chem. 1999;42:1333\u201340.","journal-title":"J Med Chem"},{"key":"5981_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvw258","volume":"113","author":"L Duluc","year":"2017","unstructured":"Duluc L, Ahmetaj-Shala B, Mitchell J, Abdul-Salam VB, Mahomed AS, Aldabbous L, et al. Tipifarnib prevents development of hypoxia-induced pulmonary hypertension. Cardiovasc Res. 2017;113:276\u201387.","journal-title":"Cardiovasc Res"},{"key":"5981_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrm.2015.11","volume":"17","author":"M Wang","year":"2016","unstructured":"Wang M, Casey PJ. Protein prenylation: unique fats make their mark on biology. Nat Rev Mol Cell Biol. 2016;17:110\u201322.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"5981_CR21","doi-asserted-by":"publisher","first-page":"13142","DOI":"10.1038\/s41598-019-49530-1","volume":"9","author":"M Avril","year":"2019","unstructured":"Avril M, Benjamin M, Dols MM, Smith. Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption. Sci Rep. 2019;9(1):13142.","journal-title":"Sci Rep"},{"key":"5981_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1046\/j.1471-4159.1997.68030991.x","volume":"68","author":"C Schulze","year":"1997","unstructured":"Schulze C, Smales C, Rubin LL, Staddon JM. Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells. J Neurochem. 1997;68:991\u20131000.","journal-title":"J Neurochem"},{"key":"5981_CR23","first-page":"103","volume":"297","author":"C Engwerda","year":"2005","unstructured":"Engwerda C, Belnoue E, Gruner AC, Renia L. Experimental models of cerebral malaria. Curr Top Microbiol Immunol. 2005;297:103\u201343.","journal-title":"Curr Top Microbiol Immunol"},{"key":"5981_CR24","first-page":"9","volume":"2018","author":"N Ghazanfari","year":"2016","unstructured":"Ghazanfari N, Mueller SN, Heath WR. Cerebral Malaria in Mouse and Man. Front Immunol. 2016;2018:9.","journal-title":"Front Immunol"},{"key":"5981_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/tmi.12313_2","volume":"19","author":"WHO","year":"2014","unstructured":"WHO. Severe malaria. Trop Med Int Health. 2014;19:7\u2013131.","journal-title":"Trop Med Int Health"},{"key":"5981_CR26","doi-asserted-by":"publisher","first-page":"13264","DOI":"10.1038\/s41598-020-70246-0","volume":"10","author":"FM Zimbres","year":"2020","unstructured":"Zimbres FM, Valenciano AL, Merino EF, Florentin A, Holderman NR, He G, et al. Metabolomics profiling reveals new aspects of dolichol biosynthesis in Plasmodium falciparum. Sci Rep. 2020;10:13264.","journal-title":"Sci Rep"},{"key":"5981_CR27","doi-asserted-by":"publisher","first-page":"13698","DOI":"10.1021\/bi026251x","volume":"41","author":"SA Holstein","year":"2002","unstructured":"Holstein SA, Wohlford-Lenane CL, Hohl RJ. Isoprenoids influence expression of Ras and Ras-related proteins. Biochemistry. 2002;41:13698\u2013704.","journal-title":"Biochemistry"},{"key":"5981_CR28","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.1021\/jo049101w","volume":"69","author":"M Kim","year":"2004","unstructured":"Kim M, Kleckley TS, Wiemer AJ, Holstein SA, Hohl RJ, Wiemer DF. Synthesis and activity of fluorescent isoprenoid pyrophosphate analogues. J Org Chem. 2004;69:8186\u201393.","journal-title":"J Org Chem"},{"key":"5981_CR29","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41557-019-0237-6","volume":"11","author":"EM Storck","year":"2019","unstructured":"Storck EM, Morales-Sanfrutos J, Serwa RA, Panyain N, Lanyon-Hogg T, Tolmachova T, et al. Dual chemical probes enable quantitative system-wide analysis of protein prenylation and prenylation dynamics. Nat Chem. 2019;11:552\u201361.","journal-title":"Nat Chem"},{"key":"5981_CR30","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1128\/IAI.00428-13","volume":"81","author":"F El-Assaad","year":"2013","unstructured":"El-Assaad F, Wheway J, Mitchell AJ, Lou J, Hunt NH, Combes V, et al. Cytoadherence of Plasmodium berghei-infected red blood cells to murine brain and lung microvascular endothelial cells in vitro. Infect Immun. 2013;81:3984\u201391.","journal-title":"Infect Immun"},{"key":"5981_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1017\/S0031182009991715","volume":"137","author":"JB de Souza","year":"2010","unstructured":"de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology. 2010;137:755\u201372.","journal-title":"Parasitology"},{"key":"5981_CR32","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 2024;52:D1265\u201375.","journal-title":"Nucleic Acids Res"},{"key":"5981_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1365-2125.2007.02883.x","volume":"64","author":"JJ Perez-Ruixo","year":"2007","unstructured":"Perez-Ruixo JJ, Chen W, Zhang S, Hayes S, Chow A. Exposure-toxicity relationships for tipifarnib in cancer patients. Br J Clin Pharmacol. 2007;64:219\u201332.","journal-title":"Br J Clin Pharmacol"},{"key":"5981_CR34","unstructured":"CDC: Treatment of Severe Malaria. Clinical Guidance: Malaria Diagnosis & Treatment in the US 2024."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05981-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05981-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05981-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:02:34Z","timestamp":1788872554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05981-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5981"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05981-2","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This animal work in this study was conducted in accordance with the guidelines in the National Institutes of Health\u2019s \u201cPublic Health Service Policy on Humane Care and Use of Laboratory Animals\u201d and the National Research Council of the National Academy of Sciences\u2019\u00a0\n                      Guide for the Care and Use of Laboratory Animals\n                      . This protocol (IA16-00626) was approved by NYU Grossman School of Medicine\u2019s Institutional Animal Care and Use Committee (IACUC).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"323"}}